Filing Analysis
SafeSpace Global Corp announced a series of investor meetings in New York City scheduled for July 21-23, 2026. The company is providing updated investor presentations via Regulation FD disclosure.
📋 Key Facts
- Company plans to meet with potential investors in New York City from July 21 through July 23, 2026.
- Investor Presentations are being made available under the 'Invest' tab on the company website (https://safespaceglobal.ai).
- The filing includes two investor presentations as Exhibits 99.1 and 99.2.
- Management intends to use these presentations for future communications with potential investors and industry analysts.
SafeSpace Global Corp announced a virtual investor webinar scheduled for July 8, 2026, to present information to current and prospective investors. The company intends to use this presentation for future marketing efforts with analysts and potential investors.
📋 Key Facts
- Virtual webinar/Investor Presentation scheduled for July 8, 2026, at 5:00 PM EDT.
- Presentation materials are made available on the company's website (https://safespaceglobal.ai).
- The presentation is intended to be used periodically for investor and analyst outreach.
SafeSpace Global Corporation announced the resignation of Board Director William Benjamin Pope, effective June 22, 2026. The company stated that the resignation was not due to any disagreements regarding operations, policies, or practices.
📋 Key Facts
- Director William Benjamin Pope resigned from the Board on June 22, 2026.
- The resignation is effective immediately as of the date reported (June 22, 2026).
- The company explicitly stated there was no disagreement with management or policies regarding the departure.
SafeSpace Global Corporation announced the resignation of its Chief Financial Officer, Timothy Brady, effective December 31, 2025. The company stated that the departure was not due to any disagreements regarding operations, policies, or practices.
🚩 Red Flags
- Sudden departure of a CFO in a micro-cap company can sometimes precede financial restatements or internal control issues, despite official denials.
- Lack of immediate succession plan mentioned in the filing.
📋 Key Facts
- Timothy Brady resigned as Chief Financial Officer on December 31, 2025.
- The resignation is effective immediately (December 31, 2025).
- The company explicitly states the departure was not due to disagreements regarding operations, policies, or practices.
SafeSpace Global Corporation announced the immediate resignation of its Chief Revenue Officer, Theo Davies, effective December 4, 2025.
🚩 Red Flags
- Immediate departure of a C-suite officer can sometimes indicate internal friction or disagreements regarding company direction/performance.
📋 Key Facts
- Theo Davies resigned from his position as Chief Revenue Officer (CRO).
- The resignation was effective immediately on December 4, 2025.
- The filing was signed by CEO Scott M. Boruff on December 5, 2025.
SafeSpace Global Corporation (formerly Healthcare Integrated Technologies Inc.) has amended its Articles of Incorporation and Bylaws to reflect a corporate name change. The rebranding is intended to align with the company's strategic shift toward AI-driven situational awareness technologies.
🚩 Red Flags
- Rebranding often accompanies a shift in business model or strategic pivot, which can sometimes be used to mask underlying operational struggles (though not explicitly stated here).
📋 Key Facts
- Company changed name from 'Healthcare Integrated Technologies Inc.' to 'SafeSpace Global Corporation'.
- Ticker symbol changed from previous identifier to 'SSGC', effective market open on April 24, 2025.
- The change was approved by the Board of Directors and filed with the Secretary of State of Nevada, effective April 17, 2025.
- CUSIP number for common stock remains unchanged.
- The company continues to trade on the OTC Pink Market.
Healthcare Integrated Technologies Inc. has appointed FKP Advisors LLC to its Board of Directors for a three-year term. The appointment includes significant equity compensation and a commission structure based on sales generated by the advisor.
🚩 Red Flags
- Related-party transaction: The board member (FKP Advisors LLC) is receiving direct sales commissions (10% new/5% renewal), which is highly unusual for a standard director role and creates potential conflicts of interest.
- Non-independent status: Explicitly classified as a non-independent board member due to the commission structure.
📋 Key Facts
- FKP Advisors LLC appointed as a non-independent board member effective April 15, 2025.
- Term length is three (3) years with rotational representation: Larry Kloess III (Year 1), Jim Fitzgerald (Year 2), and Ben Pope (Year 3).
- Compensation includes an initial stock grant and a 400,000 share restricted stock award vesting ratably through April 2028.
- FKP Advisors LLC will receive a 10% commission on new sales and a 5% renewal commission on sales they directly generate.
Healthcare Integrated Technologies Inc. announced the appointment of Theo Davies as Chief Revenue Officer (CRO), effective April 17, 2025. Mr. Davies transitions from his previous role as Chief Commercial Officer to oversee all domestic and international revenue-generating activities.
🚩 Red Flags
- Immediate vesting of 500,000 shares upon appointment may indicate aggressive compensation structuring or potential dilution concerns for existing shareholders.
📋 Key Facts
- Theo Davies appointed as Chief Revenue Officer (CRO) on April 17, 2025.
- Annual salary set at $150,000 with discretionary bonuses.
- Immediate vesting of a stock grant consisting of 500,000 shares of common stock.
- Monthly health insurance benefit allowance of $1,800.
- Commission structure: 2.0% on domestic gross revenue and 5.0% on international gross revenue (international rate reduces to 2.0% once a replacement is found).
- Mr. Davies will continue his previous Chief Commercial Officer duties during the transition period.
Healthcare Integrated Technologies Inc. announced the appointment of Anand Ijju as Chief Technology Officer (CTO), effective May 1, 2025. The appointment includes a three-year employment agreement and significant equity compensation.
🚩 Red Flags
- Significant equity dilution: The grant of 500,000 shares represents a substantial potential dilution for existing shareholders in a micro-cap context.
📋 Key Facts
- Appointment of Anand Ijju as CTO, effective May 1, 2025.
- Three-year employment agreement term.
- Annual salary set at $150,000 plus discretionary bonuses.
- Equity compensation consists of 500,000 shares of common stock.
- Vesting schedule for equity: 166,666 shares on May 1, 2026; 166,667 shares on May 1, 2027; and 166,667 shares on May 1, 2028.
Kenneth M. Greenwood has resigned from his position as Chief Product Architect, effective immediately on April 4, 2025. This departure also includes the termination of a previously established engagement agreement with Modus Novus, Inc.
🚩 Red Flags
- Immediate departure of a key technical officer (Chief Product Architect) can signal internal friction or product development delays.
- The termination of an engagement agreement only weeks after its inception (March 11 to April 4) suggests instability in the company's strategic partnerships or technical roadmap.
📋 Key Facts
- Effective date of resignation: April 4, 2025
- Departing officer: Kenneth M. Greenwood (Chief Product Architect)
- Termination of Non-Employee Chief Product Architect Engagement Agreement between Modus Novus, Inc. and the Company dated March 11, 2025
- The resignation is effective immediately.
Healthcare Integrated Technologies Inc. announced the appointment of Anthony Chapman to its Board of Directors on March 14, 2025. The appointment includes a three-year term and a compensation package consisting of restricted stock.
📋 Key Facts
- Anthony Chapman appointed to the Board of Directors on March 14, 2025.
- Term length: Three (3) years.
- Compensation: Restricted stock grant of 400,000 shares of common stock.
- Vesting schedule: Shares vest ratably over three years on March 14, 2026, 2027, and 2028.
Healthcare Integrated Technologies Inc. announced the appointment of Anthony Chapman to its Board of Directors for a three-year term, effective March 14, 2025.
📋 Key Facts
- Anthony Chapman appointed to the Board of Directors on March 14, 2025.
- Term length is three (3) years.
- Compensation consists of a restricted stock grant of 400,000 shares of common stock.
- Vesting schedule: Shares vest ratably on March 14, 2026, 2027, and 2028.
Healthcare Integrated Technologies Inc. announced a leadership realignment on March 11, 2025, involving the appointment of Ken Greenwood as Chief Product Architect. Mr. Greenwood transitions from his previous role as Chief Technology Officer (CTO) to this newly created strategic position.
🚩 Red Flags
- None identified; the filing describes a title change/realignment rather than an actual departure from the company.
📋 Key Facts
- Ken Greenwood appointed as Chief Product Architect effective March 11, 2025.
- Mr. Greenwood previously served as the company's Chief Technology Officer (CTO).
- The role change is attributed to company growth and a need to realign responsibilities.
- A non-employee agreement was executed with Mr. Greenwood on March 11, 2025.
Healthcare Integrated Technologies, Inc. reported the issuance and sale of approximately 61.3 million shares of common stock for $7.48 million between December 13, 2024, and March 11, 2025. These transactions were conducted via private placements to accredited investors under Regulation D.
🚩 Red Flags
- Significant dilution: The issuance of 61.3M shares represents a massive increase in the total share count, which was significantly lower prior to this period.
- Heavy reliance on private placements: Frequent use of unregistered equity sales can indicate difficulty accessing traditional capital markets.
📋 Key Facts
- Total shares issued/sold: 61,312,895 shares of common stock.
- Aggregate consideration received: $7.48 million.
- Period covered: December 13, 2024, to March 11, 2025.
- Total outstanding shares as of March 11, 2025: 179,105,470 shares.
- The sale was conducted via private placement (Rule 506(b) of Regulation D) to accredited investors.
Healthcare Integrated Technologies Inc. announced significant leadership changes, including the appointment of Timothy R. Brady as full-time CFO and the promotion of Dustin M. Hillis to President. Both new/promoted roles involve substantial commission and override structures based on gross revenue.
🚩 Red Flags
- High variable compensation: The CFO and President have significant percentage-based overrides/commissions on gross revenue, which can create misaligned incentives or pressure to recognize revenue aggressively.
- Significant equity issuance: Granting 2,000,000 shares to a new CFO may cause substantial dilution for existing shareholders.
📋 Key Facts
- Timothy R. Brady appointed full-time CFO effective December 1, 2024; monthly base salary of $10,000 plus 2,000,000 shares of common stock.
- Dustin M. Hillis promoted to President effective January 1, 2025; annual base salary of $100,000.
- CFO Timothy R. Brady is entitled to a 2% override on all Company sales (initial and recurring) once collected.
- President Dustin M. Hillis is entitled to a 5% commission on gross revenue collected from customers.
- Both executives are under 'Non-Employee' engagement agreements.
Ryan E. Holland has resigned from his position as a director and from all roles within the Board and its committees, effective December 20, 2024. The company stated there are no disagreements regarding operations or policies related to this resignation.
🚩 Red Flags
- Sudden departure of a director can sometimes precede internal friction, though not explicitly stated here.
📋 Key Facts
- Ryan E. Holland resigned from the Board of Directors on December 20, 2024.
- The resignation includes all positions within the Board and its committees.
- The company explicitly stated there are no disagreements with Mr. Holland regarding operations, policies, or practices.
- The Board has initiated a search for a replacement.
Healthcare Integrated Technologies Inc. announced the appointment of Micheal J. Burt to its Board of Directors on August 23, 2024. The appointment includes a three-year term with compensation structured as restricted stock awards.
🚩 Red Flags
- Significant dilution potential: The issuance of 2,000,000 restricted stock shares to a single director represents substantial equity compensation for a micro-cap company.
📋 Key Facts
- Micheal J. Burt appointed to the Board of Directors on August 23, 2024.
- Term length is three (3) years.
- Compensation consists of a 2,000,000 share restricted stock award.
- Vesting schedule: 1,000,000 shares vest immediately; 1,000,000 shares vest ratably over August 25, 2025, 2026, and 2027.
Healthcare Integrated Technologies Inc. announced the resignation of its Chief Financial Officer (CFO) and principal accounting officer, Charles B. Lobetti, III, effective July 31, 2024. The departure is reportedly to pursue other business opportunities.
🚩 Red Flags
- Sudden departure of the CFO/Principal Accounting Officer can sometimes signal internal friction or financial reporting concerns, though no specific cause was cited.
- The company is an emerging growth company trading on the OTC Bulletin Board (HITC), which typically carries higher volatility and lower liquidity.
📋 Key Facts
- Charles B. Lobetti, III resigned as CFO and principal accounting officer on July 19, 2024.
- The resignation becomes effective on July 31, 2024.
- Mr. Lobetti will remain available on a contract basis in a non-officer capacity to assist with the transition.
Healthcare Integrated Technologies Inc. announced the appointment of Ryan E. Holland to its Board of Directors on May 2, 2024. The appointment includes a three-year term with compensation structured as restricted stock grants.
🚩 Red Flags
- Significant dilution potential due to the issuance of 1,500,000 shares as compensation for a single director.
📋 Key Facts
- Ryan E. Holland appointed to the Board of Directors on May 2, 2024.
- Term length for the new director is three (3) years.
- Compensation consists of a 1,500,000 shares restricted stock grant.
- Vesting schedule for restricted stock: ratably on May 2, 2025, 2026, and 2027.